HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice

TSG-6 Produced by hMSCs Delays the Onset of Autoimmune Diabetes by Suppressing Th1 Development and Enhancing Tolerogenicity

(2013) D. J. Kota et al.   DIABETES

Mesenchymal stromal cells improve transplanted islet survival and islet function in a syngeneic mouse model

(2013) Danielle J. Borg et al.   DIABETOLOGIA

Immunotherapy in Type 1 Diabetes: A Shorter but More Winding Road?

(2012) E. Bonifacio   DIABETES

Immune Regulatory Properties of Allogeneic Adipose-Derived Mesenchymal Stem Cells in the Treatment of Experimental Autoimmune Diabetes

(2012) E. J. Bassi et al.   DIABETES

The Peri-islet Basement Membrane, a Barrier to Infiltrating Leukocytes in Type 1 Diabetes in Mouse and Human

(2012) E. Korpos et al.   DIABETES

Mesenchymal stromal cells: a key player in ‘innate tolerance’?

(2012) Francesco Dazzi et al.   IMMUNOLOGY

GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus

(2012) Johnny Ludvigsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Human Mesenchymal Stem Cells Protect Human Islets from Pro-Inflammatory Cytokines

(2012) Telford Y. Yeung et al.   PLoS One

Journey of Mesenchymal Stem Cells for Homing: Strategies to Enhance Efficacy and Safety of Stem Cell Therapy

(2012) Sung Keun Kang et al.   Stem Cells International

Follicular dendritic cells, conduits, lymphatic vessels, and high endothelial venules in tertiary lymphoid organs: Parallels with lymph node stroma

(2012) Sharon Stranford et al.   Frontiers in Immunology

Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets

(2011) Joel Montane et al.   JOURNAL OF CLINICAL INVESTIGATION

Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells

(2011) S. P. Thankamony et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mesenchymal stem cells in the treatment of autoimmune diseases

(2010) A. Tyndall et al.   ANNALS OF THE RHEUMATIC DISEASES

Mesenchymal stem cells express serine protease inhibitor to evade the host immune response

(2010) N. El Haddad et al.   BLOOD

Defining the risks of mesenchymal stromal cell therapy

(2010) Darwin J. Prockop et al.   CYTOTHERAPY

Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes

(2010) M. Jurewicz et al.   DIABETES

Mesenchymal Stem Cells Enhance Allogeneic Islet Engraftment in Nonhuman Primates

(2010) D. M. Berman et al.   DIABETES

Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and -9

(2009) Y. Ding et al.   DIABETES

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside

(2009) D. Bresson et al.   DIABETES CARE

Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells

(2009) A. M. Madec et al.   DIABETOLOGIA

Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration

(2009) Robert Sackstein   IMMUNOLOGICAL REVIEWS

Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes

(2009) P. Fiorina et al.   JOURNAL OF IMMUNOLOGY

Immunomodulation by Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Type 1 Diabetes

(2008) R. Abdi et al.   DIABETES

Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone

(2008) Robert Sackstein et al.   NATURE MEDICINE